BioregulatorEmerging Evidence✦ Khavinson Bioregulator

Cardiogen

Also known as: AEDL peptide, Heart bioregulator

Khavinson heart bioregulator that regulates cardiac gene expression and cardiovascular function.

Benefits

6

Conditions

6

Evidence

Russian clinical studies, Khavinson research+ studies

Source

Synthetic tetrapeptide bioregulator for heart

Overview

Khavinson heart bioregulator that regulates cardiac gene expression and cardiovascular function.

Mechanism of Action

Organ-specific bioregulator for heart tissue, modulates gene expression in cardiomyocytes, supports cardiac cell regeneration and function, optimizes myocardial metabolism.

Key Benefits

  • Cardiac function optimization
  • Myocardial protection
  • Cardiovascular health
  • Energy production in heart cells
  • Recovery from cardiac events
  • Anti-aging for heart

Clinical Applications

Heart failure (support)Post-myocardial infarctionCardiomyopathyAge-related cardiac declineArrhythmiasCardiovascular disease prevention

Dosing Guidelines

Oral

Typical Dose10-20 mg
FrequencyOnce daily
Duration20-30 days, 2-4 cycles per year

* Dosing should be individualized. Always consult with a qualified healthcare practitioner.

Research & Evidence

Evidence Level
Emerging
Studies

Russian clinical studies, Khavinson research

Summary

Khavinson's research shows cardiovascular benefits. Russian clinical use for cardiac support. Limited Western peer-review but established in Russian cardiology.

Safety Information

Potential Side Effects

  • Minimal
  • Well-tolerated

Contraindications

  • Pregnancy
  • Breastfeeding
  • Acute MI

Interactions

  • May complement cardiac medications

Quick Facts

CategoryBioregulator
SourceSynthetic tetrapeptide bioregulator for heart
Legal StatusDietary supplement in Russia, research compound elsewhere
Gabriel Brain Score
87/ 100

Source Your Protocol

Our preferred peptide partner offers lab-tested, COA-verified peptides with optional physician oversight. Sourced from US-regulated facilities.